Home › Funds › Avanza Fonder AB › JNJ
Avanza Fonder AB position in JNJ
JOHNSON & JOHNSON · Health Care
Avanza Fonder AB reported holding 297,973 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$78.9M, representing 1.51% of its reported portfolio and ranking #12 among its reported holdings. Avanza Fonder AB has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Avanza Fonder AB's JNJ position evolved
Avanza Fonder AB first disclosed a stake in JNJ in Q4 2024 at 258,749 shares (US$37.4M). The position peaked in Q3 2026 at 297,973 shares, worth US$78.9M. Across 8 filings, Avanza Fonder AB increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 297,973 shares valued at US$78.9M — an increase of 33,158 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 258.75K | $37.42M | New |
| Q1 2025 | 228.08K | $35.43M | Reduce |
| Q2 2025 | 234.65K | $35.84M | Add |
| Q3 2025 | 250.12K | $46.38M | Add |
| Q4 2025 | 259.06K | $53.61M | Add |
| Q1 2026 | 259.94K | $63.54M | Hold |
| Q2 2026 | 264.81K | $67.26M | Add |
| Q3 2026 | 297.97K | $78.89M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JNJ and 13F data
JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JNJ
- BlackRock Inc 212.10M sh · $53.87B · Q2 2026
- Vanguard Group 240.35M sh · $49.74B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 157.23M sh · $39.93B · Q2 2026
- STATE STREET CORP 133.48M sh · $32.63B · Q1 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 64.37M sh · $16.35B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 59.09M sh · $14.97B · Q2 2026
- Geode Capital Management 59.09M sh · $14.97B · Q2 2026
- Morgan Stanley 44.81M sh · $11.38B · Q2 2026
- Norges Bank Investment Management 31.83M sh · $8.08B · Q2 2026
- STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 31.59M sh · $8.02B · Q2 2026
- Northern Trust Corp 28.79M sh · $7.31B · Q2 2026
- Bank of America Corp 23.44M sh · $5.95B · Q2 2026
More on Avanza Fonder AB
FAQ
How long has Avanza Fonder AB held JNJ?
Avanza Fonder AB has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Avanza Fonder AB's current position in JNJ?
As of Q3 2026, Avanza Fonder AB holds 297.97K shares of JNJ (JOHNSON & JOHNSON), valued at $78.89M, representing 1.51% of its reported portfolio and ranking #12.
Has Avanza Fonder AB been buying or selling JNJ?
In the latest 13F filing (Q3 2026), Avanza Fonder AB increased its position in JNJ. The position peaked in Q3 2026 at 297.97K shares.
Which other funds hold JNJ?
Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.